Legal Opinion

Sandoz, Inc. v. The United States

Court of Customs and Patent Appeals

Decided December 18, 1969No. 5330PublishedCited by 2 opinions

1Opinion of the Court

RICH, Acting Chief Judge.

This appeal is from the judgment of the United States Customs Court, First Division, 60 Cust.Ct. 637, C.D. 3482, 285 F.Supp. 839, overruling appellant’s protest to the classification of a drug invoiced as “Digitoxin USP. XVI.” “USP. XVI” means United States Pharmacopoeia, 16th edition. “Digitoxin” is the name of the drug. The product imported was the pure drug in bulk form. It appears to be a crystalline material. It was manufactured by Sandoz Ltd. of Basel, Switzerland, by a process the details of which are a trade secret.

The parties stipulated that digitoxin is of…

Also in this document: Dissent.

2Cases cited1 opinion

  1. Sandoz, Inc. v. United StatesUnited States Customs Court · 1968

3Cited by2 opinions

  1. United States v. Pharmacia Fine Chemicals, Inc.Court of Customs and Patent Appeals · 1972
  2. Schering Corp. v. United StatesUnited States Court of International Trade · 1981

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API